Background: The role of regulatory T cells (Tregs) is now well established in the progression of hepatocellular carcinoma (HCC) linked to Hepatitis C virus (HCV) infection. However, nothing is known about the potential interplay between Tregs and HCV. In this pilot study, we have investigated the ability of Tregs to hang HCV on and the subsequent effect on their suppressive function and phenotype. Moreover, we have evaluated how HCV could promote the recruitment of Tregs by infected primary human hepatocytes.
Methods: Tregs of healthy donors were incubated with JFH-1/HCVcc. Viral inoculation was assessed using adapted assays (RT-qPCR, Flow Citometry (FACS) and Western Blot (WB). Expression of Tregs phenotypic (CD4, CD25, CD127 and Foxp3) and functional (IL-10, GZMB, TGF-β1 and IL-2) markers was monitored by RT-qPCR, FACS and ELISA. Suppressive activity was validated by suppressive assays. Tregs recruitment by infected primary hepatic cells was evaluated using Boyden Chamber.
Results: Tregs express the classical HCV receptors (CD81, CLDN1 and LDLR) and some co-receptors (CD5). HCV inoculation significantly increases the suppressive phenotype and activity of Tregs, and raises their anergy by inducing an unexpected IL-2 production. Moreover, HCV infection induces the expression of chemokines (CCL17, CXCL16, and CCL20) by primary hepatic human hepatocytes and chemokine receptors (CCR4, CXCR6 and CCR6) by Tregs. Finally, infected hepatocytes have a significantly higher potential to recruit Tregs in a seemingly CCL20-dependent manner.
Conclusions: Direct interaction between HCV and Tregs represents a newly defined mechanism that could potentiate HCV immune evasion and favor intratumoral recruitment contributing to HCC progression.
Keywords: HCV; HCV/JFH-1; chemokines; immune escape; regulatory T cells.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.Front Immunol. 2015 Feb 25;6:49. doi: 10.3389/fimmu.2015.00049. eCollection 2015. Front Immunol. 2015. PMID: 25767469 Free PMC article.
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.PLoS One. 2017 Jan 23;12(1):e0170516. doi: 10.1371/journal.pone.0170516. eCollection 2017. PLoS One. 2017. PMID: 28114346 Free PMC article.
An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection.Int Immunopharmacol. 2017 Sep;50:87-94. doi: 10.1016/j.intimp.2017.06.015. Epub 2017 Jun 20. Int Immunopharmacol. 2017. PMID: 28644966
Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.Chronic Dis Transl Med. 2016 Nov 9;2(2):67-80. doi: 10.1016/j.cdtm.2016.09.001. eCollection 2016 Jun. Chronic Dis Transl Med. 2016. PMID: 29063027 Free PMC article. Review.
Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases.Front Immunol. 2018 Feb 26;9:340. doi: 10.3389/fimmu.2018.00340. eCollection 2018. Front Immunol. 2018. PMID: 29535721 Free PMC article. Review.